The Latest Breaking News from UNH

The healthcare industry harbors a robust stance capable of withstanding various market challenges, thanks to the ceaseless requisite for its services. This is entwined with an escalating demand for healthcare facilities, pharmaceutical solutions, and pioneering medical breakthroughs, laying a robust foundation for the industry's continued prosperity. Given this backdrop, fundamentally…

Well-received earnings from Taiwan Semiconductor generated a halo effect on other semiconductor stocks.

The healthcare industry is well-positioned for expansion due to rising healthcare expenditures and growing demand for quality treatment. Given the industry’s solid long-term prospects, investors might consider buying quality stocks Cigna (CI), UnitedHealth Group (UNH) and Elevance Health (ELV). Read on….

With bond yields closing in on the 5% threshold, mega-cap blue-chip stocks with rock-solid balance sheets are some of the best places to park your investing capital.

UNH is on the brink of substantial growth, characterized by its health plan's widespread adoption, strategic alliances, and comprehensive services. Furthermore, bolstered by a strong first-half performance, the company has revised its earnings projections. Does this make UNH an ideal buy before its third-quarter earnings release? Let's find out.

American companies continued to slow their rates of dividend growth after a period of remarkable resilience during the pandemic.

Healthcare stocks, such as UnitedHealth Group, can provide investors with stability. Though it has underperformed in 2023, now could be a good time to scoop up shares of UNH.

The health insurance industry is well-positioned for growth thanks to the rising healthcare costs, the prevalence of chronic diseases, and the growing demand for quality healthcare. To that end, it could be wise to add fundamentally strong medical stocks UnitedHealth Group (UNH), Humana (HUM), and Molina Healthcare (MOH) to one’s…

Healthcare giant UnitedHealth Group (UNH) recently reported its fiscal second-quarter earnings, surpassing Wall Street's expectations. The results followed UNH's prior update regarding a surge in non-urgent surgeries and outpatient demand. Considering this, could UNH be an ideal addition to your portfolio? Read more to find out.